Matrine Sodium Chloride Injection

This product can inhibit the occurrence of cachexia in tumor-bearing mice, inhibit the growth of cancer cells, and prolong the survival time of tumor-bearing mice by more than double. This product can inhibit the production of cachectin in tumor cells, and also inhibit the effect of cachectin on normal cells, thereby preventing cachexia in tumor patients.

The main ingredient of this product and its chemical name is oxymatrine.

This product is a colorless or almost colorless clear liquid.

Mainly used for the treatment of chronic hepatitis B.

Intravenous drip. Once a day, 0.6g each time, two months as a course of treatment. Or follow the doctor's advice.

The incidence of adverse reactions of this product is low. Common adverse reactions include dizziness, nausea, vomiting, bitter taste in the mouth, diarrhea, upper abdominal discomfort or pain, and occasionally rash, chest tightness, and fever. Symptoms generally resolve on their own. Some patients may experience redness at the injection site.

It is contraindicated for those who are allergic to this product.

It has a synergistic effect with central nervous system depressants such as chloral hydrate, an antagonistic effect on central nervous system stimulants such as phenylpropanol, and can facilitate the convulsive reaction of strychnine.

Keep tightly closed.

100ml: 0.6g of oxymatrine and 0.9g of sodium chloride

Jiangsu Huai'an Shuanghe Pharmaceutical Co., Ltd.

• Founded in:

  2001-11-26

• Address:

  Jiangning Industrial Park, Huaiyin Economic Development Zone, Jiangsu

• Tax NO.:

  91320804733327617X

• Registered Funds:

  74.5609 million yuan

• Email:

  Log in to view